Hydro International announces retirement of CEO

The Chief Executive Officer (CEO) and Director of Hydro International is stepping down, the water treatment company announced Tuesday.

The Chief Executive Officer (CEO) and Director of Hydro International is stepping down, the water treatment company announced Tuesday.

Steve Hides will retire from the positions following the appointment of a successor and a hand-over period.

However, he will remain with the company as he takes on the new responsibility of overseeing US operations and for driving growth in Central and South America.

The company, which also had operations in the UK and Ireland, is actively searching for a new CEO and a further announcement will be made in due course.

"Steve has served the business with loyalty and distinction for many years,"Chairman Roger Lockwood said.

"While Steve will be stepping down as CEO he will not be leaving the business; he will be applying his 30 years of Hydro experience by taking on a new challenge responsible for the oversight of the existing US businesses as well as planned expansion into Central and South America.

"We are confident that Steve will continue to serve Hydro well in this new role and will build on our recent success in developing the US market."

Hides has served as CEO for the past 12 years and he said was looking forward to the new challenges ahead.

"The business has grown significantly and I am proud of the progress the company has made since being appointed CEO in December 2000," he said.

"It was not an easy decision, but after 12 years at the helm the time has now come for me to take on a new role as we prepare Hydro for the next stage of its development."

RD

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022